Fetal programming of the growth hormone-insulin-like growth factor axis

Trends in Endocrinology and Metabolism

Volumn 13, Issue 9, 2002, Pages 392-397

  Holt, Richard I G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; HUMAN GROWTH HORMONE;

ADULT DISEASE; BIRTH WEIGHT; BODY SIZE; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CHRONIC DISEASE; ENDOCRINE PROGRAMMING; ENDOCRINE SYSTEM; FETUS DEVELOPMENT; FETUS GROWTH; GLUCOSE METABOLISM; HUMAN; HYPOTHESIS; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; NONHUMAN; NUTRITION; OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ADULT; ANIMAL; FEMALE; NEWBORN; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

ADULT; ANIMALS; BIRTH WEIGHT; CARDIOVASCULAR DISEASES; FEMALE; FETAL GROWTH RETARDATION; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; NUTRITION PHYSIOLOGY; OSTEOPOROSIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOMATOMEDINS;

EID: 0036834832     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00697-5     Document Type: Review

References (55)

1. Barker, D.J. (1999) Fetal origins of cardiovascular disease. Ann. Med. 31(Suppl. 1), 3-6
2. Hales, C.N. and Barker, D.J. (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595-601
3. Le Roith, D. et al. (2001) What is the role of circulating IGF-I? Trends Endocrinol. Metab. 12, 48-52
4. Hwa, V. et al. (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761-787
5. Pombo, M. et al. (2001) Hormonal control of growth hormone secretion. Horm. Res. 55 (Suppl. 1), 11-16
6. Walton, A. and Hammond, J. (1938) The maternal effects on growth and conformation in Shire horse-Shetland pony crosses. Proc. R. Soc. Lond. Ser. B 125, 311-335
7. Gluckman, P.D. (1997) Endocrine and nutritional regulation of prenatal growth. Acta Paediatr. Suppl. 423, 153-157
8. Morton, N.E. (1955) The inheritance of human birth weight. Ann. Hum. Genet. 19, 262-268
9. Penrose, L.S. (1952) Data on genetics of birth weight. Ann. Eugen. 16, 378-381
10. Gluckman, P.D. and Harding, J.E. (1997) The physiology and pathophysiology of intrauterine growth retardation. Horm. Res. 48 (Suppl. 1), 11-16
11. Baker, J. et al. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82
12. Yakar, S. et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 96, 7324-7329
13. Sjogren, K. et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U. S. A. 9, 7088-7092
14. Le Roith, D. et al. (2001) The somatomedin hypothesis: 2001. Endocr. Rev. 22, 53-74
15. Woods, K.A. et al. (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New Engl. J. Med. 335, 1363-1367
16. Vaessen, N. et al. (2002) Association between genetic variation in the gene for insulin-like growth factor-I and low birth weight. Lancet 359, 1036-1037
17. Gluckman, P.D. et al. (1987) The effects of pancreatectomy on the plasma concentrations of insulin-like growth factors 1 and 2 in the sheep fetus. J. Dev. Physiol. 9, 79-88
18. Oliver, M.H. et al. (1993) Glucose but not a mixed amino acid infusion regulates plasma insulin-like growth factor-I concentrations in fetal sheep. Pediatr. Res. 34, 62-65
19. Langford, K. et al. (1994) The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur. J. Clin. Invest. 24, 851-856
20. Chard, T. (1994) Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul. 4, 91-100
21. Cutfield, W.S. et al. (2002) IGFs and binding proteins in short children with intrauterine growth retardation. J. Clin. Endocrinol. Metab. 87, 235-239
22. Popovici, R.M. et al. (2001) Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin. Endocrinol. Metab. 86, 2653-2659
23. Gluckman, P.D. et al. (1992) Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J. Pediatr. 121, 920-923
24. Huchard, H. (1895) Anatomie patholigique, lésions et troubles cardiovasculaires de l'acromegalie. J. Practiciens 9, 249-250
25. Colao, A. et al. (2001) Growth hormone and the heart. Clin. Endocrinol. 54, 137-154
26. Erfurth, E.M. et al. (2001) Premature mortality and hypopituitarism. Lancet 357, 1972-1973
27. Maison, P. et al. (1998) Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. Brit. Med. J. 316, 1132-1133
28. Janssen, J.A. et al. (1998) Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin. Endocrinol. 48, 471-478
29. Vaessen, N. et al. (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50, 637-642
30. Holt, R.I.G. et al. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet. Med. (in press)
31. Ozanne, S.E. and Hales, C.N. (2002) Programming of glucose-insulin metabolism. Trends Endocrinol. Metab. 13, 368-373
32. Ljunghall, S. et al. (1992) Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J. Intern. Med. 232, 59-64
33. Gomez, J.M. et al. (2000) Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement. Horm. Metab. Res. 32, 66-70
34. Erdtsieck, R.J. et al. (1995) Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial. Clin. Endocrinol. 43, 557-565
35. Gonnelli, S. et al. (1997) Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study. Clin. Endocrinol. 46, 55-61
36. Jansson, J.O. et al. (1985) Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 117, 1881-1889
37. Jansson, J.O. et al. (1985) Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6, 128-150
38. Legraverend, C. et al. (1992) Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6, 259-266
39. Waxman, D.J. et al. (1995) Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J. Biol. Chem. 270, 13262-13270
40. Jansson, J.O. and Frohman, L.A. (1987) Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats. Endocrinology 121, 1417-1423
41. Harel, Z. and Tannenbaum, G.S. (1995) Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr. Res. 38, 747-753
42. Thissen, J.P. et al. (1994) Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15, 80-101
43. Deiber, M. et al. (1989) Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J. Clin. Endocrinol. Metab. 68, 232-234
44. Albertsson-Wikland, K. et al. (1998) Children born small-for-gestational age: postnatal growth and hormonal status. Horm. Res. 49 (Suppl. 2), 7-13
45. Cacciari, E. et al. (1999) Birth weight affects final height in patients treated for growth hormone deficiency. Clin. Endocrinol. 51, 733-739
46. Cianfarani, S. et al. (2002) Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr. Res. 51, 94-99
47. Fall, C.H. et al. (1995) Size at birth and plasma insulin-like growth factor-1 concentrations. Arch. Dis. Child. 73, 287-293
48. Holt, R.I.G. et al. (2001) Ageing and physical fitness are more important than obesity in determining exercise induced generation of growth hormone. J. Clin. Endocrinol. Metab. 86, 5715-5720
49. Parfitt, V.J. et al. (1998) Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin-like growth factor-1. Clin. Endocrinol. 49, 647-652
50. Flanagan, D.E. et al. (1997) Urinary growth hormone following exercise to assess growth hormone production in adults. Clin. Endocrinol. 46, 425-429
51. Wallace, J.D. et al. (2000) Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J. Clin. Endocrinol. Metab. 85, 124-133
52. Flanagan, D.E. et al. (1999) Reduced foetal growth and growth hormone secretion in adult life. Clin. Endocrinol. 50, 735-740
53. Fall, C. et al. (1998) Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis. J. Clin. Endocrinol. Metab. 83, 135-139
54. Jernstrom, H. and Olsson, H. (1998) Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women. Int. J. Gynaecol. Obstet. 62,11-18
55. Flanagan, D.E. et al. (2001) The association between birth weight and IGF-I activity in young adults. Pediatr. Res. 50 (Suppl.)Abstr. 11/10